CIK 0000719135
- Non-accelerated filer
- Smaller reporting company
Apyx Medical Corp
Sign in to watch- Ticker
- APYX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 112644611
- Phone
- +1 727-384-2323
- Business address
- 5115 ULMERTON ROAD, CLEARWATER, FL, 33760
- Former names
- BOVIE MEDICAL CORP, BOVIE MEDICAL Corp, AN CON GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-08-17 | McCarthy John J. III Chief CommercializationOfficer | Purchase | +90,750 | $3.30 | $299K | 115,750 |
| 2016-07-28 | Waldman Lawrence Director | Grant or award · Stock Option (Option to Buy) | +12,000 | 12,000 | ||
| 2016-07-28 | Orsatti Charles T. Director | Grant or award · Stock Option (Option to Buy) | +12,000 | 12,000 | ||
| 2016-07-28 | Geraghty Michael Director | Grant or award · Stock Option (Option to Buy) | +12,000 | 12,000 | ||
| 2016-07-28 | Andres John C. Director | Grant or award · Stock Option (Option to Buy) | +12,000 | 12,000 | ||
| 2016-07-28 | Orsatti Charles T. Director | Grant or award · Stock Option (Option to Buy) | +12,000 | 12,000 | ||
| 2016-07-28 | Waldman Lawrence Director | Grant or award · Stock Option (Option to Buy) | +12,000 | 12,000 | ||
| 2016-07-28 | Orsatti Charles T. Director | Grant or award · Stock Option (Option to Buy) | +12,000 | 12,000 | ||
| 2016-07-28 | Geraghty Michael Director | Grant or award · Stock Option (Option to Buy) | +12,000 | 12,000 | ||
| 2016-07-28 | Andres John C. Director | Grant or award · Stock Option (Option to Buy) | +12,000 | 12,000 | ||
| 2015-12-22 | McCarthy John J. III Chief Commercialization Office | Purchase | +25,000 | $1.98 | $49K | 25,000 |
| 2015-12-21 | CITRONOWICZ MOSHE Sr. V.P. of Operations | Purchase | +20,000 | $1.84 | $37K | 426,504 |
| 2015-12-21 | Gershon Robert Chief Executive Officer | Purchase | +10,000 | $1.82 | $18K | 30,000 |
| 2015-10-14 | Ewers Jay D. Chief Financial Officer | Grant or award · Stock Option (Option to Buy) | +65,000 | 65,000 | ||
| 2015-08-14 | Gershon Robert Chief Executive Officer | Purchase | +20,000 | $2.39 | $48K | 20,000 |
| 2015-07-16 | Geraghty Michael Director | Grant or award · Stock Option (Option to Buy) | +12,500 | 12,500 | ||
| 2015-07-16 | Orsatti Charles T. Director | Grant or award · Stock Option (Option to Buy) | +12,500 | 12,500 | ||
| 2015-07-16 | Waldman Lawrence Director | Grant or award · Stock Option (Option to Buy) | +12,500 | 12,500 | ||
| 2015-07-16 | Andres John C. Director | Grant or award · Stock Option (Option to Buy) | +12,500 | 12,500 | ||
| 2015-03-17 | Sheffield Ian Director | Grant or award | +480,000 | $2.50 | $1.2M | 480,000 |
Page 9 of 13 · 250 trades